Conference Reports for NATAP
Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026
Back
 
Tweet
Twice-Yearly Lenacapavir, Teropavimab, and Zinlirvimab for HIV-1: 52 Week Resistance Analysis